Boston, MA -- (SBWIRE) -- 06/27/2013 -- PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013

Summary
"PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013" applies GlobalData's proprietary ranking methodology to compare the competitive position of 30 generic pharmaceutical companies across various markets on 12 financial metrics. The performances of these companies are analyzed based on financial performance, cost-containment, capital structure, and efficiency to illustrate the different strategies these companies are using to increase shareholder value and capture market share from branded pharmaceuticals manufacturers. In addition to the financial metrics, this report presents SWOT analyses of the major players, and describes the operations strategy of these companies.

View Full Report Details and Table of Contents

Throughout the report, GlobalData's analysts provide you with expert insight, expanding on each strategy and factor discussed, with the aim of providing you with the tools needed for making informed business decisions.

Scope

- The report provides analysis of the key drivers and trends shaping the global generics industry.
- The report identifies the key generic players in various markets, including a special focus on emerging markets such as India, China, Russia, and Brazil.
- Furthermore, it provides detailed analysis of the various generic markets including the US, Europe, APAC, and BRIC.
- The report contains expert insights on the corporate strategies of generic companies seeking competitive advantage in the highly competitive generics industry.

Reasons to Get This Report

- Benchmark your company's performance against other generic pharmaceutical companies to identify strengths that can be leveraged and/or areas of possible improvement
- Analyze and track the strategies that successful generic pharmaceutical companies are using to gain share in the increasingly competitive market
- Understand the underlying financial metrics that differentiate certain companies from the pack in terms of growth and profitability, spending, asset structure, and efficiency
- Use this information as an independent source for your due diligence and transaction strategy

Companies Mentioned in this Report: Sun Pharmaceuticals: The Benchmark Leader, Sandoz, Pharmstandard, Teva Pharmaceuticals, Actavis, Mylan, Ranbaxy, Dr. Reddy's, Covidien, Hospira

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- PharmaLeaders: Innovative Mid-Cap Biotechnology Benchmark Report - Financial Benchmarking, Pipeline Assessment & Competitive Analysis of Innovative Biotechs
- Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs
- Generic Drugs: Global collaboration opportunities
- The Pharmaceutical Market: USA
- Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020
- PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013
- Parkinson's Disease Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020
- Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020
- Asia-Pacific Leading Department Stores - Company Benchmarking Analysis Report
- Leading Middle East and African Clothing, Footwear, Accessories and Luxury Goods Retailers - Company Benchmarking Analysis Report